| abstract |
Embodiments of the invention relate to kinase inhibitors, such as interleukin receptor-associated kinase inhibitors (IRAKs), and compositions comprising such inhibitors. The invention also relates to methods of making and using the compounds and compositions. The compounds and / or compositions according to the invention can be used to treat or prevent a disease or condition associated with kinases, particularly a disease or condition associated with IRAK. |